Works matching IS 25233548 AND DT 2023 AND VI 43 AND IP 3

Results: 10

μ‐opioid receptor agonist facilitates circulating tumor cell formation in bladder cancer via the MOR/AKT/Slug pathway: a comprehensive study including randomized controlled trial.
Published in:
Cancer Communications, 2023, v. 43, n. 3, p. 365, doi. 10.1002/cac2.12408
By:
- Wang, Xiaoqiang;
- Zhang, Song;
- Jin, Di;
- Luo, Jiamei;
- Shi, Yumiao;
- Zhang, Yiqi;
- Wu, Lingling;
- Song, Yanling;
- Su, Diansan;
- Pan, Zhiying;
- Chen, Haige;
- Cao, Ming;
- Yang, Chaoyong;
- Yu, Weifeng;
- Tian, Jie
Publication type:
Article
Aerobic glycolysis promotes tumor immune evasion and tumor cell stemness through the noncanonical function of hexokinase 2.
Published in:
Cancer Communications, 2023, v. 43, n. 3, p. 387, doi. 10.1002/cac2.12404
By:
- He, Haiyan;
- Xiao, Liwei;
- Wang, Juhong;
- Guo, Dong;
- Lu, Zhimin
Publication type:
Article
METTL5 stabilizes c‐Myc by facilitating USP5 translation to reprogram glucose metabolism and promote hepatocellular carcinoma progression.
Published in:
Cancer Communications, 2023, v. 43, n. 3, p. 338, doi. 10.1002/cac2.12403
By:
- Xia, Peng;
- Zhang, Hao;
- Lu, Haofeng;
- Xu, Kequan;
- Jiang, Xiang;
- Jiang, Yuke;
- Gongye, Xiangdong;
- Chen, Zhang;
- Liu, Jie;
- Chen, Xi;
- Ma, Weijie;
- Zhang, Zhonglin;
- Yuan, Yufeng
Publication type:
Article
Serologic status and safety of inactivated Covid‐19 vaccine for hepatocellular carcinoma patients with cirrhosis after curative liver resection.
Published in:
Cancer Communications, 2023, v. 43, n. 3, p. 409, doi. 10.1002/cac2.12398
By:
- Liu, Fuchen;
- Feng, Xiaochen;
- Du, Jin;
- Ruan, Minghao;
- Liu, Hui
Publication type:
Article
C‐terminal variants of the P2X7 receptor are associated with prostate cancer progression and bone metastasis – evidence from clinical and pre‐clinical data.
Published in:
Cancer Communications, 2023, v. 43, n. 3, p. 400, doi. 10.1002/cac2.12391
By:
- Song, Haiping;
- Arredondo Carrera, Hector Manuel;
- Sprules, Alexandria;
- Ji, Ying;
- Zhang, Tongsong;
- He, Jiepei;
- Lawrence, Eleanor;
- Gartland, Alison;
- Luo, Jian;
- Wang, Ning
Publication type:
Article
Activation mechanisms of clinically distinct B‐Raf V600E and V600K mutants.
Published in:
Cancer Communications, 2023, v. 43, n. 3, p. 405, doi. 10.1002/cac2.12395
By:
- Zhang, Mingzhen;
- Maloney, Ryan;
- Liu, Yonglan;
- Jang, Hyunbum;
- Nussinov, Ruth
Publication type:
Article
Novel endogenous endoplasmic reticulum transmembrane protein SURF4 suppresses cell death by negatively regulating the STING‐STAT6 axis in myeloid leukemia.
Published in:
Cancer Communications, 2023, v. 43, n. 3, p. 395, doi. 10.1002/cac2.12390
By:
- Kim, Jayoung;
- Lee, Hansong;
- Hong, Chae Mi;
- Nam, Ji Ho;
- Yeo, Hye Ju;
- Cho, Woo Hyun;
- Kim, Hyung‐Sik;
- Hong, Changwan;
- Kim, Yun Hak;
- Lee, Dongjun
Publication type:
Article
Prognostic impact of circulating tumor cells in patients with soft‐tissue sarcomas: a prospective study.
Published in:
Cancer Communications, 2023, v. 43, n. 3, p. 391, doi. 10.1002/cac2.12389
By:
- Blanchi, Julie;
- Laroche‐Clary, Audrey;
- Le Loarer, François;
- Bonhomme, Benjamin;
- Italiano, Antoine
Publication type:
Article
Resistance to antibody‐drug conjugates in breast cancer: mechanisms and solutions.
Published in:
Cancer Communications, 2023, v. 43, n. 3, p. 297, doi. 10.1002/cac2.12387
By:
- Chen, Yu‐Fei;
- Xu, Ying‐ying;
- Shao, Zhi‐Ming;
- Yu, Ke‐Da
Publication type:
Article
Issue Information.
Published in:
Cancer Communications, 2023, v. 43, n. 3, p. 295, doi. 10.1002/cac2.12300
Publication type:
Article